Naslov
ABCB1 and ABCG2 Drug Transporters Are Differentially Expressed in Non-Small Cell Lung Cancers (NSCLC) and Expression Is Modified by Cisplatin Treatment via Altered Wnt Signaling

Autori
Vesel, M. ; Rapp, J. ; Feller, D. ; Kiss, E. ; Jaromi, L. ; Meggyes, M. ; Miskei, Gy.. ; Duga, B. ; Smuk, G. ; Laszlo, T. ; Karner, Ivan ; Pongracz, J.E.

Izvornik
Respiratory research (1465-993X) 18 (2017); 52, 12

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
ABC transporters, Wnt signaling, Cisplatin, Lung cancer

Sažetak
Lung cancer (LC) is still the most common cause of cancer related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of all LC cases but is not a single entity. It is now accepted that, apart from the characteristic driver mutations, the unique molecular signatures of adeno- (AC) and squamous cell carcinomas (SCC), the two most common NSCLC subtypes should be taken into consideration for their management. Therapeutic interventions, however, frequently lead to chemotherapy resistance highlighting the need for in-depth analysis of regulatory mechanisms of multidrug resistance to increase therapeutic efficiency.Non-canonical Wnt5a and canonical Wnt7b and ABC transporter expressions were tested in primary human LC (n= 90) resections of AC and SCC. To investigate drug transporter activity, a three dimensional (3D)human lung aggregate tissue model was set up using differentiated primary human lung cell types. Following modification of the canonical, beta-catenin dependent Wnt pathway or treatment with cisplatin, drug transporter analysis was performed at mRNA, protein and functional level using qRT-PCR, immunohistochemistry, immune-fluorescent staining and transport function analysis. Non-canonical Wnt5a is significantly up-regulated in SCC samples making the microenvironment different from AC, where the beta-catenin dependent Wnt7b is more prominent. In primary cancer tissues ABCB1 and ABCG2 expression levels were different in the two NSCLC subtypes. Non-canonical rhWnt5a induced down-regulation of both ABCB1 and ABCG2 transporters in the primary human lung aggregate tissue model recreating the SCC-like transporter pattern. Inhibition of the beta-catenin or canonical Wnt pathway resulted in similar down-regulation of both ABC transporter expression and function. In contrast, cisplatin, the frequently used adjuvant chemotherapeutic agent, activated beta-catenin dependent signaling that lead to up-regulation of both ABCB1 and ABCG2 transporter expression and activity.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA